Clinical Trials Directory

Trials / Completed

CompletedNCT05095077

Effects of Single Dose Tadalafil on Urethral and Anal Closure Function

Effects of Single Dose Tadalafil on Urethral and Anal Closure Function and on Urinary Flow in Healthy Females: A Randomised, Controlled, Double-blinded, Two-period Cross-over Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University Hospital Bispebjerg and Frederiksberg · Academic / Other
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of the trial is to assess the effect of tadalafil compared to placebo (inactive comparator) on the urethral - and anal pressure and on urine flow in healthy females. Further, the purpose of the trial is to evaluate the potential for going forward with studies of tadalafil in patients suffering from urine or fecal incontinence.

Conditions

Interventions

TypeNameDescription
DRUGTadalafil 40 MGSingle dose on study day 1/2
DRUGPlaceboIdentical to active IMP

Timeline

Start date
2021-08-01
Primary completion
2021-12-30
Completion
2022-01-01
First posted
2021-10-27
Last updated
2022-04-06

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05095077. Inclusion in this directory is not an endorsement.